^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CT032

i
Other names: CT032, CD19 redirected autologous cells, anti-CD19 chimeric antigen receptor T cell therapy, CAR-CD19 T cells
Associations
Company:
CARsgen, Korea Kolmar
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations